Effect of intra-venous ocytocine injection after fetal expulsion in management of third-stage of labor after second trimester medical pregnancy terminatio

Phase 1

Active, not recruiting

• Conditions: second trimester medical pregnancy termination; MedDRA version: 19.0Level: LLTClassification code 10043285Term: Termination of pregnancy - medicalSystem Organ Class: 100000004865; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]

• Registration Number: EUCTR2016-003143-11-FR
• Lead Sponsor: CHU de Bordeaux

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-08-12
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Not Recruiting
• Sex: Female
• Target Recruitment: 114

Inclusion Criteria

• Women over 18
• to use a medical termination of pregnancy between 14 and 28 weeks of amenorrhea
• affiliated person or beneficiary of a social security scheme.
• Free, informed and writing signed by the participant and the investigator (no later than the day of inclusion and foremost need examination by research).
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 114
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

• fetal death in utero
• pre-existing cardiovascular disease
• minor patients
• Contraindications to the use of oxytocin according to the summary of product characteristics.
• Denial of participation in the study

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified